Letter to the editor on 'Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial' by Udwadia et al

Autor: Mahender Kumar Medisetty, Atul Patel, Sanjay Pujari
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: International Journal of Infectious Diseases, Vol 105, Iss , Pp 722- (2021)
Druh dokumentu: article
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2021.02.035
Databáze: Directory of Open Access Journals